UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The emerging role of the androgen receptor in bladder cancer

Endocrine-related cancer, 2015-10, Vol.22 (5), p.R265-R277

2015

Volltextzugriff (PDF)

Non-circadian aspects of BHLHE40 cellular function in cancer

Genes & cancer, 2020, Vol.11 (1-2), p.1-19

2020

Volltextzugriff (PDF)

Progression of prostate cancer: Multiple pathways to androgen independence

Cancer letters, 2009-02, Vol.274 (2), p.177-186

2009

Volltextzugriff (PDF)

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

Scientific reports, 2023-01, Vol.13 (1), p.1762-1762, Article 1762

2023

Volltextzugriff (PDF)

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism

Signal transduction and targeted therapy, 2023-09, Vol.8 (1), p.361-361, Article 361

2023

Volltextzugriff (PDF)

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11395

2023

Volltextzugriff (PDF)

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

Scientific reports, 2023-06, Vol.13 (1), p.9617-16, Article 9617

2023

Volltextzugriff (PDF)

Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases

Clinical cancer research, 2009-02, Vol.15 (3), p.788-796

2009

Volltextzugriff (PDF)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Biomedicines, 2020-10, Vol.8 (10), p.422

2020

Volltextzugriff (PDF)

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

Biomedicines, 2023-08, Vol.11 (8), p.2215

2023

Volltextzugriff (PDF)

miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1

Molecular carcinogenesis, 2016-05, Vol.55 (5), p.757-767

2016

Volltextzugriff (PDF)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans

Biomedicines, 2021-10, Vol.9 (10), p.1472

2021

Volltextzugriff (PDF)

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9001-9005

2007

Volltextzugriff (PDF)

ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines

The Journal of biological chemistry, 2010-01, Vol.285 (4), p.2368-2374

2010

Volltextzugriff (PDF)

Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines

Endocrine-related cancer, 2010-12, Vol.17 (4), p.857-873

2010

Volltextzugriff (PDF)

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

Immunology, endocrine & metabolic agents in medicinal chemistry, 2011-06, Vol.11 (2), p.131-149

2011

Volltextzugriff (PDF)

The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells

The Prostate, 2012-05, Vol.72 (6), p.649-660

2012

Volltextzugriff (PDF)

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

Molecular cancer research, 2008-05, Vol.6 (5), p.808-818

2008

Volltextzugriff (PDF)

The E2F transcription factor is a cellular target for the RB protein

Cell, 1991-06, Vol.65 (6), p.1053-1061

1991

Volltextzugriff (PDF)

Abstract 6264: Role of Nuclear ErbB3 localization in regulating ligand-dependent ErbB2-ErbB3 heterodimer activation and downstream targets in prostate cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6264-6264

2024

Volltextzugriff (PDF)

Abstract 4619: Prolonged inhibition of androgen receptor signaling induces expression of Nuclear ErbB3 which renders prostate cancer cells susceptible to targeted inhibitors

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4619-4619

2024

Volltextzugriff (PDF)

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

Oncogene, 2017-11, Vol.36 (46), p.6359-6373

2017

Volltextzugriff (PDF)

The Role of EGFR Family Inhibitors in Muscle Invasive Bladder Cancer: A Review of Clinical Data and Molecular Evidence

The Journal of urology, 2015-01, Vol.193 (1), p.19-29

2015

Volltextzugriff (PDF)

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

The Journal of biological chemistry, 2023-08, Vol.299 (8), p.104973, Article 104973

2023

Volltextzugriff (PDF)

Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis

Cancer letters, 2021-04, Vol.504, p.49-57

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The emerging role of the androgen receptor in bladder cancer

Non-circadian aspects of BHLHE40 cellular function in cancer

Progression of prostate cancer: Multiple pathways to androgen independence

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

ERK Regulates Calpain 2-induced Androgen Receptor Proteolysis in CWR22 Relapsed Prostate Tumor Cell Lines

Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

The E2F transcription factor is a cellular target for the RB protein

Abstract 6264: Role of Nuclear ErbB3 localization in regulating ligand-dependent ErbB2-ErbB3 heterodimer activation and downstream targets in prostate cancer

Abstract 4619: Prolonged inhibition of androgen receptor signaling induces expression of Nuclear ErbB3 which renders prostate cancer cells susceptible to targeted inhibitors

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer

The Role of EGFR Family Inhibitors in Muscle Invasive Bladder Cancer: A Review of Clinical Data and Molecular Evidence

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase

Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis

Suchergebnisse filtern